CIK 0001390478
- Non-accelerated filer
- Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-200-5278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $716,682
- in 3 filings
Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-12-29 | CYTRX CORP 10% owner | Sale | −2,593,881 | $2.20 | $5.7M | 0 |
| 2010-12-22 | CYTRX CORP 10% owner | Sale | −500,000 | $2.65 | $1.3M | 2,593,881 |
| 2010-06-30 | CYTRX CORP 10% owner | Sale | −2,000,000 | $2.55 | $5.1M | 3,093,881 |
| 2010-03-26 | CYTRX CORP 10% owner | Sale | −675,000 | $5.70 | $3.8M | 5,093,881 |
| 2009-09-23 | CYTRX CORP 10% owner | Sale | −500,000 | $2.50 | $1.3M | 5,768,881 |
| 2008-03-11 | CYTRX CORP 10% owner | Other disposition | −4,526,624 | 6,296,575 | ||
| 2008-03-11 | CYTRX CORP 10% owner | Other disposition | −27,694 | 6,268,881 |
Page 1 of 1 · 7 trades